B. Riley Equities Analysts Boost Earnings Estimates for SNDX
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Equities research analysts at B. Riley lifted their Q2 2025 earnings estimates for Syndax Pharmaceuticals in a research note issued on Tuesday, May 6th. B. Riley analyst K. Patel now expects that the company will earn ($0.93) per share for the quarter, up from their previous estimate […]
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) – Equities research analysts at B. Riley lifted their Q2 2025 earnings estimates for Syndax Pharmaceuticals in a research note issued on Tuesday, May 6th. B. Riley analyst K. Patel now expects that the company will earn ($0.93) per share for the quarter, up from their previous estimate […]
